Why we need better drug monitoring
Monday, January 10, 2011 - 13:40
in Health & Medicine
The use of recombinant activated factor 7 (rFVIIa) despite its potential for adverse events displays the serious shortcomings of Canada's current drug surveillance system, according to a commentary published in CMAJ (Canadian Medical Association Journal)...